person

Eric V.

Country
France
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
17
Sites with multiple studies

Has run more than one trial at 17 of 131 partner sites.

Specializations

Renal Oncology

The investigator specializes in advanced treatment approaches for renal cell carcinoma (RCC), with particular focus on combination immunotherapy and targeted therapies. Their research encompasses both metastatic RCC and post-surgical treatment scenarios.

  • Advanced and metastatic RCC management
  • Immunotherapy combinations
  • Post-surgical recurrence prevention

The investigator addresses various stages of renal cancer, from localized disease to advanced metastatic cases.

Hematologic Oncology

Their expertise extends to multiple myeloma treatment, particularly focusing on novel therapeutic approaches for both newly diagnosed and relapsed cases. The investigator explores innovative treatment durations and combinations for optimal patient outcomes.

  • Treatment strategies for frail patients
  • Relapsed multiple myeloma therapy
  • Novel drug combinations

Special attention is given to developing treatment protocols for patients ineligible for intensive therapy.

Innovative Therapeutic Approaches

The investigator explores targeted therapy combinations and immunotherapy applications across different oncological conditions. Their work includes evaluation of both fixed-duration and continuous treatment protocols.

  • Combination immunotherapy strategies
  • Treatment duration optimization
  • Novel drug delivery methods

Research focuses on personalized treatment approaches based on patient risk factors and disease characteristics.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.